Asia · Markets & Finance · Tech in Asia

Nvidia-backed AI drug developer Iambic raises $150m in IPO

Published by Tech in Asia · Singapore 3 h ago

Iambic said it will use the proceeds to advance three early-stage cancer drug candidates.

Read the full article on Tech in Asia Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.techinasia.com)

Also worth reading

The Straits Times Business

Keeping the haze out: Malls shut automated doors, suspend outdoor activities

Bajaj Housing Finance Q2 Results: Focus on asset quality, guidance after 25% growth in disbursements, AUM

The Business Times

Singapore’s worsening haze threatens business activity, but GDP impact ‘limited’: analysts

Business Standard

Gold: Sell on rallies as rate hike concerns weigh on metal, says analyst

Nilesh Shah of Kotak says easing tax burden may help attract foreign flows, but won't be enough

The Economic Times

India's GDP to grow 7.1-7.3% in FY27: Deloitte